1 January – 30 June (unaudited)
|
kEUR |
H1 2024 |
H1 2023 |
|
|
|
|
|
|
|
Result for the period |
|
-11,386 |
-34,266 |
|
|
|
|
|
|
Other comprehensive income to be reclassified to profit or loss in subsequent periods |
|
|
|
|
Exchange differences on translation of foreign operations, net of tax |
|
-8,709 |
-5,720 |
|
Net other comprehensive income to be reclassified to profit or loss in subsequent periods |
|
-8,709 |
-5,720 |
|
|
|
|
|
|
Other comprehensive income not to be reclassified to profit or loss in subsequent periods |
|
|
|
|
Remeasurement gain / (loss) on defined benefit plans |
|
-2,590 |
2,892 |
|
Income tax effect |
|
626 |
-661 |
|
Net other comprehensive income not to be reclassified to profit or loss in subsequent periods |
|
-1,964 |
2,231 |
|
Other comprehensive result for the period, net of taxes |
|
-10,673 |
-3,489 |
|
|
|
|
|
|
Total comprehensive result for the period, net of taxes |
|
-22,059 |
-37,755 |
|
|
|
|
|
|
Attributable to shareholders of PolyPeptide Group AG |
|
-22,059 |
-37,755 |